arrow
N

Nicole Le Corre

Pontificia Universidad Catolica de Chile
H指数:14
被引数:801

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

New Andes virus isolate haplotype obtained during prospective close contacts follow-up of an Hantavirus cardiopulmonary syndrome fatal case, Chile.

新安第斯病毒分离株单倍型,源自智利汉坦病毒心肺综合征死亡病例的密切接触者前瞻性随访研究。

2025-09-160
OAAI
CONVALESCENT PLASMA THERAPY AND LONG-TERM SARS-COV-2 ANTIVIRAL IMMUNE RESPONSE IN A PROSPECTIVE COHORT OF PATIENTS WITH COVID-19

康复期血浆疗法及长期SARS-CoV-2抗病毒免疫反应:一项针对COVID-19患者的前瞻性队列研究

2025-07-090
OAAI
Viral shedding and viraemia of Andes virus during acute hantavirus infection: a prospective study
2024-07-012
OAAI
Immune responses during COVID-19 breakthrough cases in vaccinated children and adolescents
2024-05-150
OAAI
Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac®) According to Age Group in a Pediatric Population from 3 to 17 Years Old, in an Open-Label Study in Chile
2023-09-264
OAAI
Influence of SARS-CoV-2 mRNA Vaccine Booster among Cancer Patients on Active Treatment Previously Immunized with Inactivated versus mRNA Vaccines: A Prospective Cohort Study

癌症患者中SARS-CoV-2 mRNA疫苗加强剂对先前用灭活疫苗与mRNA疫苗免疫的积极治疗的影响: 一项前瞻性队列研究

2023-07-032
OAAI
Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in Children
MBIO
IF4.7
2022-12-2017
OAAI
SARS-CoV-2 vaccine booster in solid organ transplant recipients previously immunised with inactivated versus mRNA vaccines: A prospective cohort study
2022-12-0120
OAAI
Safety and Non-Inferiority Evaluation of Two Immunization Schedules with an Inactivated SARS-CoV-2 Vaccine in Adults: A Randomized Clinical Trial

成人SARS-CoV-2灭活疫苗两种预防接种方案的安全性和非劣效性评价: 一项随机临床试验

2022-07-0610
OAAI
Reduced Immune Response to Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Cohort of Immunocompromised Patients in Chile

智利免疫功能低下患者对灭活新型冠状病毒疫苗的免疫反应降低

2022-03-0736
OA
Insights into neutralizing antibody responses in individuals exposed to SARS-CoV-2 in Chile
2021-02-1226
OAAI